These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8680898)

  • 1. 5-aminosalicylates in inflammatory bowel disease--the more the merrier?
    Forbes A
    Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1017-9. PubMed ID: 8680898
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].
    Schölmerich J
    Internist (Berl); 1997 Jun; 38(6):582-9. PubMed ID: 9265003
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminosalicylates for the treatment of inflammatory bowel disease.
    Leichtner AM
    J Pediatr Gastroenterol Nutr; 1995 Oct; 21(3):245-52. PubMed ID: 8523207
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mesalazine].
    Engelhardt K; Mohr K
    Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
    Hartmann F; Plauth M
    Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
    [No Abstract]   [Full Text] [Related]  

  • 8. Current medical therapy for inflammatory bowel disease.
    Bonner GF
    South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changing treatment of inflammatory bowel diseases].
    Karvonen AL; Matikainen M; Turunen U
    Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
    Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [5-aminosalicylic acid and chronic inflammatory bowel diseases in children].
    Klotz U
    Klin Padiatr; 1995; 207(5):285-7. PubMed ID: 7500605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid].
    Frol'kis AV
    Ter Arkh; 1996; 68(2):75-7. PubMed ID: 8771669
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aminosalicylates in the treatment of idiopathic inflammatory bowel disease].
    Lukás K
    Vnitr Lek; 1996 Feb; 42(2):117-9. PubMed ID: 8686186
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-ASA enema therapy.
    Hanauer SB
    Neth J Med; 1989 Jun; 35 Suppl 1():S11-20. PubMed ID: 2702307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminosalicylates in the treatment of inflammatory bowel disease.
    Sutherland LR
    Inflamm Bowel Dis; 1998 May; 4(2):113. PubMed ID: 9687217
    [No Abstract]   [Full Text] [Related]  

  • 17. Folliculitis and mesalamine.
    Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
    Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inflammatory bowel disease. Should aminosalicylates be administered in a single daily dose in ulcerative colitis?].
    Sicilia Aladrén B
    Gastroenterol Hepatol; 2008; 31(6):396-7. PubMed ID: 18570819
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Aminosalicylic acid, 1,000-mg caplets versus 500-mg tablets, in maintenance of remission in ulcerative colitis.
    Odes HS
    J Clin Gastroenterol; 1997 Jun; 24(4):287-8. PubMed ID: 9252863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.